Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 24, Issue 23, Pages 6756-6768
Publisher
Oxford University Press (OUP)
Online
2015-09-19
DOI
10.1093/hmg/ddv381
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How much dystrophin is enough: the physiological consequences of different levels of dystrophin in themdxmouse
- (2015) Caroline Godfrey et al. HUMAN MOLECULAR GENETICS
- Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice
- (2015) Corinne A. Betts et al. Scientific Reports
- The many roles of PGC-1α in muscle — recent developments
- (2014) Mun Chun Chan et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics
- (2013) Rui M M Branca et al. NATURE METHODS
- Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover
- (2013) Thomas C. Roberts et al. NUCLEIC ACIDS RESEARCH
- Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: An Age- and Muscle-Related Reappraisal
- (2013) Sarah R. Pigozzo et al. PLoS One
- Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
- (2013) Henrik J. Johansson et al. Nature Communications
- Functions of S100 Proteins
- (2012) R. Donato et al. CURRENT MOLECULAR MEDICINE
- Loss of miR-29 in Myoblasts Contributes to Dystrophic Muscle Pathogenesis
- (2012) Lijun Wang et al. MOLECULAR THERAPY
- Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy
- (2012) Thomas C Roberts et al. Molecular Therapy-Nucleic Acids
- Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
- (2012) Corinne Betts et al. Molecular Therapy-Nucleic Acids
- Cancer-Related PRUNE2 Protein Is Associated with Nucleotides and Is Highly Expressed in Mature Nerve Tissues
- (2011) Eiji Iwama et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Quantitative Proteomic Analysis of Dystrophic Dog Muscle
- (2011) Laetitia Guevel et al. JOURNAL OF PROTEOME RESEARCH
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Pip5 Transduction Peptides Direct High Efficiency Oligonucleotide-mediated Dystrophin Exon Skipping in Heart and Phenotypic Correction in mdx Mice
- (2011) HaiFang Yin et al. MOLECULAR THERAPY
- Global quantification of mammalian gene expression control
- (2011) Björn Schwanhäusser et al. NATURE
- MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics
- (2011) Lily Ting et al. NATURE METHODS
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques
- (2011) Kay Ohlendieck Skeletal Muscle
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials
- (2010) Virginia Arechavala-Gomeza et al. NEUROMUSCULAR DISORDERS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia
- (2009) Simona Greco et al. FASEB JOURNAL
- Correlation of mRNA and protein in complex biological samples
- (2009) Tobias Maier et al. FEBS LETTERS
- A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice
- (2009) HaiFang Yin et al. HUMAN MOLECULAR GENETICS
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Integrating multiple 'omics' analysis for microbial biology: application and methodologies
- (2009) W. Zhang et al. MICROBIOLOGY-SGM
- Truncated dystrophins can influence neuromuscular synapse structure
- (2009) Glen B. Banks et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Global signatures of protein and mRNA expression levels
- (2009) Raquel de Sousa Abreu et al. Molecular BioSystems
- ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
- (2009) J. Chen et al. NUCLEIC ACIDS RESEARCH
- Muscle genome-wide expression profiling during disease evolution in mdx mice
- (2009) Mario Marotta et al. PHYSIOLOGICAL GENOMICS
- Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences
- (2008) Arjun Raj et al. CELL
- The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts
- (2008) Baiqiu Wang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The impact of microRNAs on protein output
- (2008) Daehyun Baek et al. NATURE
- Widespread changes in protein synthesis induced by microRNAs
- (2008) Matthias Selbach et al. NATURE
- Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy
- (2007) Guilian Sun et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started